ZARR

News and price dashboard

Swept 18:10
Sources
27, all reachable
Items
48963
Flagged
5789
Last swept
18:10

STOCKS

120

OPTIONS

25

COMING UP

US majors and your names' earnings, next 7 days

Full calendar

Everything else — unscored, browse only, never pushed

Brief

Bank earnings day, mixed results

The biggest single theme in the feed is the start of Q3 bank reporting. Wells Fargo, covered in full, slipped 1.6% pre-open: net income of $6.0 billion or $1.87 a share was up 13% year over year and a touch above consensus, but revenue of $21.87 billion missed by roughly $440 million, with the shortfall in capital markets and Corporate and Investment Banking, and the Corporate segment posting a loss where income was expected. Net interest income of $12.52 billion also came in light, though management held full-year NII guidance and guided to about $13 billion for Q4. Consumer, Commercial and Wealth all beat. A HUD probe into past mortgage lending programs has been hanging over the name. Alongside that, headline-only items say Goldman Sachs beat by $3.92 with revenue above estimates and profit rising on equities strength, Citi's profit jumped 40% on investment banking, services and wealth, and JPMorgan shares fell as profit missed and fixed-income trading disappointed. Bank of America, Morgan Stanley and BlackRock report Wednesday.

BioNTech trial miss

BioNTech fell nearly 6% pre-open after its mRNA cancer immunotherapy BNT113 failed the first of two dual primary endpoints, progression-free survival, in the AHEAD-MERIT Phase 2/3 trial in unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma. The trial tested BNT113 plus pembrolizumab against pembrolizumab alone first-line, and the PFS improvement was not statistically significant at this interim look. CMO Özlem Türeci said the data support continued evaluation and show the drug is engaging its intended mechanism. The second dual primary endpoint, overall survival, is still outstanding. The article notes this lands on top of existing uncertainty: co-founders Ugur Sahin and Türeci plan to leave by the end of 2026 to start an independent venture, Sahin's direct shareholding has gone to zero with his stake now held indirectly, and Morgan Stanley had previously trimmed its target. Shares were at $90.15 against a prior close of $95.84, nearer the $79.52 52-week low than the $124 high.

VF upgraded twice on Vans

VF Corp rallied 3.9% pre-open on two upgrades. Piper Sandler went to Overweight from Neutral with a $20 target, up from $16, citing its Fall Teen Survey of roughly 9,000 respondents showing Vans holding a top footwear spot among males and ending a multi-survey decline, plus gains among upper-income male teens. Truist moved to Buy from Hold and nearly doubled its target to $20 from $14, arguing fashion is rotating away from athletic looks and retailers are filling shelf space vacated by Nike lifestyle pullbacks. A JPMorgan upgrade to Neutral the prior session had already helped. Stifel stayed at Hold with a $17 target, flagging Vans wholesale orders as the swing factor. Separately in the feed, a headline-only Piper note says Nike continues to lose teen share as On Running gains, which fits the same survey work.

Domino's beats but comps stall

Domino's fell 3.1% pre-open despite beating on both lines, with diluted EPS of $4.60 against roughly $4.36 expected and revenue of $1.185 billion. The problem was US same-store sales up just 0.3%, down from 5.3% franchise comp growth a year earlier, plus year-to-date operating cash flow off 5.7% to $520.6 million and free cash flow down 7.2% to $459.8 million. It was the first earnings call under new CEO Joe Jordan. Morgan Stanley had cut its target to $357 from $370 the day before, keeping Equalweight and citing category and TAM concerns, quick-service softness and rising rates. The stock sits about 32% below its $442.35 52-week high.

J&J beats on EPS, devices drag

Johnson & Johnson slid 2.5% pre-open. Adjusted EPS of $2.59 beat the $2.53 consensus and revenue of $25.4 billion was slightly ahead and up 5.9%, but GAAP EPS was just $0.09 and GAAP net earnings fell 95.9% to $210 million, reflecting a one-time charge for the proposed talc litigation resolution, the Firefly Bio acquisition and the Sail Biomedicines collaboration. Pharma sales rose 7.7% to $16.76 billion while medtech rose only 2.5% to $8.6 billion, flat outside the US, with the article attributing the weakness to geopolitical issues. Full-year adjusted EPS guidance was raised to $11.05 to $11.15 against $11.08 consensus. The proposed $5.5 billion talc settlement remains conditional on claimant acceptance. The piece notes zero positive and 12 negative EPS revisions in the last 90 days.

Visa gets China clearing approval

Visa rose 1.4% pre-open after the People's Bank of China approved Visa Information Technology (Beijing) to begin formal preparations for a domestic bankcard clearing institution. Visa has up to a year to complete preparations before applying for a full operating licence. CEO Ryan McInerney called it a significant step forward. Mastercard and American Express already hold similar approvals. Baird raised its target to $430 from $420 on Monday with an Outperform rating ahead of fiscal Q4 results on October 27, expecting a modest beat but some growth deceleration into fiscal 2027. The stock set a 52-week high of $391.81 in the prior session and traded to $394.83 pre-market.

Chips, oil and the macro backdrop

The session's wider tone, per the TSX futures piece, was a split tape: Dow futures up, Nasdaq futures down 0.7%, chipmakers under pressure with the industry tracker off 2.7% on Monday and Korean tech hit too, partly on reports of advances by China's ChangXin Memory Technologies narrowing the AI gap. Vital Knowledge noted the debate is why tech has traded so poorly for several sessions. Oil fell after Russia said diesel exports may exceed the volumes in its supply deal with the US, pulling back from Monday's spike that followed Houthi strikes on Saudi infrastructure; gold rebounded. September CPI lands Wednesday, with the Fed expected to hold this month after September's hike. Headline-only items round this out: OPEC raised its 2027 demand growth forecast to 2.55M bpd while cutting 2026 to 180,000 bpd, Saudi production reportedly at about 8.4M b/d in September, the Houthis warning Riyadh of a harsh response, the Kremlin denying the diesel deal is linked to Ukraine talks, and a BofA poll showing tech overweight at its highest since August 2020.

Analyst notes and smaller company items

Mizuho raised Energy Transfer to $26 from $25 with an Outperform rating, expecting commodity earnings to moderate from strong Q2 2026 levels but staying constructive; the note cites the Vaquero acquisition expanding the Delaware footprint as a strategically sensible if pricey bolt-on, projects ramping, and the Waha price recovery reducing optimisation gains. The stock was $20.41, up 30.41% year to date with a 6.66% yield. Needham lifted SentinelOne to $31 from $26, keeping Buy, after a pre-quiet-period conversation convinced it the three emerging products, now over half of total ARR, are not cannibalising endpoint; net revenue retention is back above 110% and revenue grew 21% to $1.1 billion over twelve months. Note the tension in the feed: separate headline-only items say SentinelOne fell 7% after announcing a $1.25 billion convertible notes offering. Dauch Corporation named Nathan Iles CFO effective December 1, joining as SVP Finance on November 2, succeeding Christopher May who becomes EVP and Chief Administrative Officer overseeing IT and HR; Iles was most recently CFO at Standard Motor Products. A long tail of other analyst headlines sits in the list without detail, including Northland cutting Enovix on silicon anode delays, Mizuho cutting Enlight on valuation, Wells Fargo cutting Bristol-Myers on Eliquis concerns, Jefferies initiating Electra at Buy, and Deutsche Bank raising its outlook on semiconductor equipment.

Noise in the feed

A large share of the 200 items is retail chart commentary from TradingView on gold, EURUSD, Bitcoin and index futures, which is directional opinion rather than news, plus routine SEC Form 4 and Form 144 filings with no accompanying detail. Two Trump Truth Social posts were read in full and contain no market content: both are reposts of other users' screenshots, one about Mike Tyson and loyalty, the other a Fox commentary clip about midterm campaigning.

20 read in full, 200 items in the section

Feed

159 stories · 159 newCross-publisher stories only
  1. Pinned
  2. 159 new
  3. B L KASHYAP
    TradingView [COMMENT]
  4. Jefferies examines HealthEquity stock short interest rise
    Investing.com - news 2 itemsalso Investing.com - UK
  5. Marsh names Nicole Delimitros to lead employee benefits unit
    Investing.com - news 2 itemsalso Investing.com - UK
  6. Eurusd
    TradingView [COMMENT]
  7. Stocks Decline as Chipmakers Retreat
    Nasdaq - stocks
  8. Strong Short Setup
    TradingView [COMMENT]
  9. Form 4 Global X Funds For: 13 October
    Investing.com - UK 4 itemsalso Investing.com - UK
  10. POTENTIAL BULLISH REVERSAL
    TradingView [COMMENT]
  11. Goldman Sachs earnings analysis: questions answered and next catalysts
    Investing.com - news 3 itemsalso Investing.com - UK
  12. Taysha Gene Therapies stock hits 52-week low at 3.69 USD
    Investing.com - news 2 itemsalso Investing.com - UK
  13. bajaj finserv
    TradingView [COMMENT]
  14. Nas100 BUY
    TradingView [COMMENT]
  15. JNJ: Raised Guidance, Broken Trend
    TradingView [COMMENT]
  16. BTC London session: bid wall at 83,389 pulled
    TradingView [COMMENT]
  17. Mettler-Toledo stock hits 52-week high at 1586.0 USD
    Investing.com - news 9 items
  18. XAUUSD GOLD SELL SETUP | 4H BEARISH CONTINUATION
    TradingView [COMMENT]
  19. GOLD 1H CHART - MARKET ROUTE MAP
    TradingView [COMMENT] 2 items
  20. Ethereum Wave Analysis – 13 October 2026
    TradingView [COMMENT] 6 itemsalso TradingView
  21. THE KOG REPORT - Update
    TradingView [COMMENT]
  22. Head and Shoulder formation on Bitcoin 1D
    TradingView [COMMENT]
  23. Don't Sweat ON Semiconductor Stock's Recent Pullback
    Schaeffer's Research [COMMENT]
  24. BEL
    TradingView [COMMENT]
  25. WTI Crude Oil – Wolfe Wave Pattern Analysis
    TradingView [COMMENT]
  26. Applied Materials shares slide as chip equipment outlook remains uncertain
    Investing.com - news 2 itemsalso Investing.com - UK
  27. Why is MongoDB stock rallying today?
    Investing.com - UK 28 itemsalso Investing.com - news
  28. Pinterest Stock Flashing Sell Signal Right Now
    Schaeffer's Research [COMMENT]
  29. Form 4 Tesla Inc For: 13 October
    Investing.com - UK 4 items
  30. GBPJPY SHORT POSITION
    TradingView [COMMENT]
  31. European stocks fall as U.S. bank earnings roll in
    Investing.com - news 2 itemsalso Investing.com - UK
  32. Maruti
    TradingView [COMMENT]
  33. BITCOIN (BTC/USD): Major Structure Breakout
    TradingView [COMMENT]
  34. MongoDB gains as BofA highlights long-term AI strategy potential
    Investing.com - news 2 itemsalso Investing.com - UK
  35. Silver Elephant closes $840,000 private placement financing
    Investing.com - news 2 itemsalso Investing.com - UK
  36. U.K. stocks lower at close of trade; Investing.com United Kingdom 100 down 0.08%
    Investing.com - news 3 itemsalso Investing.com - UK
  37. Sweden stocks higher at close of trade; OMX Stockholm 30 up 0.21%
    Investing.com - news 2 itemsalso Investing.com - UK
  38. Spain stocks lower at close of trade; IBEX 35 down 0.36%
    Investing.com - news 2 itemsalso Investing.com - UK
  39. Portugal shares higher at close of trade; PSI up 0.73%
    Investing.com - UK 3 itemsalso Investing.com - news
  40. MASTERING MARKET STRUCTURE
    TradingView [COMMENT]
  41. What Is a Short Squeeze?
    TradingView [COMMENT] 2 itemsalso TradingView
  42. PEPE: Bullish Reversal Before a Major Rally?
    TradingView [COMMENT]
  43. Truist Securities Upgrades V.F. to Buy from Hold
    Nasdaq - stocks 2 items
  44. KKR - Drop to Trend Line Then Pump
    TradingView [COMMENT]
  45. GBPCHF: Expecting Bearish Movement! Here is Why:
    TradingView [COMMENT]
  46. $ULTA IH&S or C&H break out
    TradingView [COMMENT]
  47. BTC.D 1W outlook
    TradingView [COMMENT]
  48. EURNZD: Long Signal Explained
    TradingView [COMMENT]
  49. VEEV - Establishing An Uptrend
    TradingView [COMMENT]
  50. Crh stock hits 52-week low at 80.1 USD
    Investing.com - UK 7 itemsalso Investing.com - news
  51. Martin Shkreli violated lifetime pharma industry ban, FTC and states say
    Investing.com - news 2 publishers · 2 items
  52. 10/13/2026 OHM Hinges & Results
    TradingView [COMMENT] 2 items
  53. NZDCHF Technical Analysis! SELL!
    TradingView [COMMENT]
  54. Software stocks: Box and Navan lead after Citi investor meetings
    Investing.com - news 2 itemsalso Investing.com - UK
  55. Earnings call transcript: Wells Fargo tops Q3 2026 EPS forecast, revenue misses
    Investing.com - news 2 itemsalso Investing.com - UK
  56. WMT #1: Every High Below the Last
    TradingView [COMMENT]
  57. DXY - Long Bearish Trend Reversal
    TradingView [COMMENT]
  58. OXM (Oxford Industries): Bottom or Pit Stop?
    TradingView [COMMENT]
  59. GBPJPY A Fall Expected! SELL!
    TradingView [COMMENT]
  60. BTC - The Level That Decides the Next Leg
    TradingView [COMMENT]
  61. Caliber Mining and Logistics Ltd.
    TradingView [COMMENT]
  62. PBF Energy stock hits all-time high at 89.49 USD
    Investing.com - UK 6 itemsalso Investing.com - news
  63. ES Market Analysis | S&P 500 Oct 13, 2026
    TradingView [COMMENT]
  64. Zeta Global Holdings Corp stock hits 52-week high at 34.83 USD
    Investing.com - UK 2 itemsalso Investing.com - news
  65. DIS - Long Continuation
    TradingView [COMMENT]
  66. Safety Insurance Group stock reaches all-time high at 104.02 USD
    Investing.com - UK 2 itemsalso Investing.com - news
  67. Raymond James reiterates Strong Buy on Terex stock amid selloff
    Investing.com - UK 2 itemsalso Investing.com - news
  68. 3 Stocks Seeing Notable Price Action Today: BMBL, CIFR, HIMS
    Schaeffer's Research [COMMENT]
  69. INCOMING BUY
    TradingView [COMMENT]
  70. Built Cybernetics publishes circular ahead of general meeting
    Investing.com - UK 2 itemsalso Investing.com - news
  71. Form 4 Progressive Corp: Maribel Pumarejo (Chief Marketing Officer) For: 9 October
    Investing.com - UK 2 itemsalso Investing.com - UK
  72. VietNam Holding completes share redemption at 371.45p
    Investing.com - UK 2 itemsalso Investing.com - news
  73. $AMZN
    TradingView [COMMENT]
  74. A POSSIBLE BUY
    TradingView [COMMENT]
  75. DXY — Potential Exhaustion at Resistance?
    TradingView [COMMENT]
  76. Boeing reports Q3 aircraft deliveries across commercial, defense units
    Investing.com - UK 2 itemsalso Investing.com - news
  77. ORS acquires Techniweld and janitorial brands from Essendant
    Investing.com - UK 2 itemsalso Investing.com - news
  78. Goldman Sachs Q3 2026 slides: record advisory fees drive strong beat
    Investing.com - UK 2 itemsalso Investing.com - news
  79. GOLD Pullback Expected! Sell!
    TradingView [COMMENT]
  80. Fermi stock gets $20 price target at Texas Capital on AMD deal
    Investing.com - UK 2 itemsalso Investing.com - news
  81. FTC targets Martin Shkreli over pharma stock trading and market commentary
    Investing.com - UK 2 itemsalso Investing.com - news
  82. MSFT - Touch on Strong Trend Line
    TradingView [COMMENT]
  83. Huntington Ingalls Industries stock hits 52-week low at $256.71
    Investing.com - UK 2 itemsalso Investing.com - news
  84. Innovative industrial properties’ Alan Gold buys $1m in preferred stock
    Investing.com - UK 2 itemsalso Investing.com - news
  85. SPSY: Record Volume Meets Strong Demand at 130p
    TradingView [COMMENT]